Amphastar Pharmaceuticals (AMPH) Shares Outstanding (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Shares Outstanding (Entity) of $45.3 million for Q1 2026, down 4.87% year-over-year from $47.6 million in Q1 2025, and down 3.04% quarter-over-quarter from $46.7 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Shares Outstanding (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $45.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 4.87% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at $45.3 million (down 4.87% YoY), while the FY2025 annual figure was $46.7 million, down 3.48% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $45.3 million, down from $46.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $58.1 million in Q4 2022, with the low at $45.3 million in Q1 2026.
- The 5-year median for Shares Outstanding (Entity) is $48.4 million (2023), against an average of $50.1 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) climbed 4.19% in 2022, then decreased 16.94% in 2023.
- Amphastar Pharmaceuticals' Shares Outstanding (Entity) stood at $58.1 million in 2022, then decreased by 16.94% to $48.3 million in 2023, then advanced by 0.34% to $48.4 million in 2024, then dropped by 3.48% to $46.7 million in 2025, then decreased by 3.04% to $45.3 million in 2026.
- Business Quant data shows AMPH's Shares Outstanding (Entity) at $45.3 million in Q1 2026, $46.7 million in Q4 2025, and $46.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 832.44 Mn |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn | 43.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.64 Mn |
| Mar 31, 2026 | 45.32 Mn |
| Dec 31, 2025 | 46.74 Mn |
| Sep 30, 2025 | 46.47 Mn |
| Jun 30, 2025 | 46.95 Mn |
| Mar 31, 2025 | 47.64 Mn |
| Dec 31, 2024 | 48.43 Mn |
| Sep 30, 2024 | 48.62 Mn |
| Jun 30, 2024 | 48.91 Mn |
| Mar 31, 2024 | 48.21 Mn |
| Dec 31, 2023 | 48.27 Mn |
| Sep 30, 2023 | 48.70 Mn |
| Jun 30, 2023 | 48.40 Mn |
| Mar 31, 2023 | 48.00 Mn |
| Dec 31, 2022 | 48.55 Mn |
| Sep 30, 2022 | 48.90 Mn |
| Jun 30, 2022 | 48.86 Mn |
| Mar 31, 2022 | 48.14 Mn |
| Dec 31, 2021 | 47.78 Mn |
| Sep 30, 2021 | 48.02 Mn |